期刊文献+

左卡尼汀联合卡托普利对扩张型心肌病合并心力衰竭的疗效观察 被引量:3

Effect of levocarnitine combined with captopril in the treatment of dilated cardiomyopathy complicated with heart failure
原文传递
导出
摘要 目的研究左卡尼汀联合卡托普利治疗扩张型心肌病合并心力衰竭的临床效果。方法选取2016年4月至2017年12月胶州市人民医院收治的92例扩张型心肌病合并心力衰竭患者,依照治疗方案分为对照组和观察组,各46例。两组均接受常规抗心衰治疗,对照组接受左卡尼汀注射液治疗,观察组接受左卡尼汀注射液联合卡托普利治疗。比较两组治疗前后左心室射血分数(LVEF),左心室收缩末期内径(LVESD),血清脑钠肽(BNP)、转化因子β1 (TGF-β1)水平及MLHFQ评分。结果治疗后观察组LVEF大于对照组,LVESD小于对照组(P <0. 05);治疗后观察组血清BNP水平低于对照组,血清TGF-β1水平高于对照组(P <0. 05);治疗后观察组MLHFQ评分低于对照组(P <0. 05)。结论左卡尼汀注射液联合卡托普利治疗扩张型心肌病合并心力衰竭,能有效改善患者心功能,降低血清BNP水平,提高TGF-β1水平,提升其生活质量。 Objective To study the effect of levocarnitine combined with captopril in the treatment of dilated cardiomyopathy complicated with heart failure. Methods A total of 92 patients with dilated cardiomyopathy complicated with heart failure treated in Jiaozhou People ’s Hospital from April of 2016 to December of 2017 were selected and divided into control group and observation group according to the treatment plans,46 cases in each group. Both groups received routine anti-heart failure treatment. The control group received levocarnitine injection treatment,and the observation group received levocarnitine injection combined with captopril treatment. Left ventricular ejection fraction( LVEF),left ventricular end-systolic diameter( LVESD),serum brain natriuretic peptide( BNP),transforming factor-β1( TGF-β1) levels and MLHFQ scores were compared between the two groups before and after treatment. Results After treatment,the LVEF of the observation group was higher than that of the control group,and the LVESD of the observation group was lower than that of the control group( P < 0. 05). After treatment,the serum BNP level of the observation group was lower than that of the control group,and the serum TGF-β1 level was higher than that of the control group( P < 0. 05). After treatment,the MLHFQ score of the observation group was lower than that of the control group( P < 0. 05). Conclusion In the treatment of dilated cardiomyopathy complicated with heart failure,levocarnitine injection combined with captopril can effectively improve cardiac function,reduce serum BNP level,improve the level of TGF-β1,and improve the quality of life of patients with dilated cardiomyopathy
作者 贾鹏远 张亮 Jia Pengyuan;Zhang Liang(Department of Neurology,Jiaozhou People’s Hospital,Qingdao 266300,China;Community Health Service Center of Yunxi Street,Jiaozhou,Qingdao 266300,China)
出处 《中华心脏与心律电子杂志》 2018年第2期95-98,共4页 Chinese Journal of Heart and Heart Rhythm(Electronic Edition)
关键词 左卡尼汀 卡托普利 扩张型心肌病 心力衰竭 心功能 脑钠肽 转化生长因子Β1 levocarnitine captopril dilated cardiomyopathy heart failure brain natriuretic peptide transforming growth factor-β1
  • 相关文献

参考文献8

二级参考文献51

  • 1Jing Zhu,Duy Nguyen,Hong Ouyang,Xiao-Hui Zhang,Xiao-Ming Chen,Kang Zhang.Inhibition of RhoA/Rho-kinase pathway suppresses the expression of extracellular matrix induced by CTGF or TGF-β in ARPE-19[J].International Journal of Ophthalmology(English edition),2013,6(1):8-14. 被引量:21
  • 2黄俊,覃国辉,马业新.转化生长因子-β_1及其胞内信号通路SMADs在大鼠心肌肥厚中的作用[J].中国病理生理杂志,2004,20(9):1601-1604. 被引量:11
  • 3陈灏环,心脏病学[M].第5版.北京:人民卫生出版社,2000:1273-1277.
  • 4Mson E, Stofan DA, Szweda LI. Inhibition of very longchain acyl-COA dehydrogenase during cardiac ischemia[J]. Arch Biochem Biophys ,2005 ,437(2) : 138-143.
  • 5Carvani M,Reda E,Arrigoni-Martelli E. Ragulation bycarnitine of myocardial fatty acid and carbohydrate metab-olism under normal and pathological conditions [J]. BasicRes Cardiol,2000,95(1) : 75-83.
  • 6Nemoto S,Yasuhara K, Nakamura K,et al. Plasm acarnitine concentrations in patients undergoing open heartsurgery[J]. Ann Thorac Cardiovasc Surg,2004,10(1) : 19-22.
  • 7Kosmicki M . Metabolic drags in treatment of iscaemicheart disease[J], Doctora Guided,2001,1 (1) : 57-64.
  • 8Rizos L. Three-year surrival of patients with heart failurecaused by dilated cardiomyopathy and L-earnitine admin-istration [J]. Am Heart J ,2000 ,139(2pt3) : 121-123.
  • 9NDREPEPA G, BRAUN S, MEHILLI J, et al. Accuracy of N-terminal probrain natriuretic peptide to predict mortality or detect acute isehemia in patients with coronary artery disease [ J ]. Cardiology, 2008, 109 ( 4 ) : 249-257.
  • 10DICKSTEIN K, COHEN-SOLAL A, FILIPPATOS G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 : the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC ( HFA ) and endorsed by the European Society of Intensive Care Medicine (ESICM) [ J]. Eur Heart J, 2008,29 ( 19 ) : 2388- 2442.

共引文献126

同被引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部